A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

Inclusion Criteria

• •\- Number of sites/patients: Approximately 18 sites and 125 patients.
• •1. Patient must be able to understand, either orally or in writing, and be able to consent and complete the required assessments and procedures.
• •2. Patient provides signed/dated Informed Consent and Health Insurance Portability and Accountability Act (HIPAA) of 1996 authorization after receiving a full explanation of the extent and nature of the study.
• •3. Patient must be at least 18 years of age and undergoing one of the specified minor surgical procedures at the time of screening.
• •4. If female, patient must be surgically sterile, postmenopausal, or not pregnant or lactating and must have been using an acceptable method of birth control for at least 1 month prior to dosing, with a negative urine pregnancy test result at screening and predose.
• •5. Patient meets American Society of Anesthesiologists (ASA) Physical Classification System status of P1 to P4.